Impact of vessel maturation on antiangiogenic therapy in ovarian cancer (Q36593708)

15 August 2017

Impact of vessel maturation on antiangiogenic therapy in ovarian cancer (English)

1 reference

15 August 2017

1 reference

angiogenesis inhibitor

1 reference

9

David M Gershenson

1 reference

15 August 2017

14

Anil K Sood

1 reference

15 August 2017

Chunhua Lu

1

1 reference

15 August 2017

Premal H Thaker

2

1 reference

15 August 2017

Yvonne G Lin

3

1 reference

15 August 2017

Whitney Spannuth

4

1 reference

15 August 2017

Charles N Landen

5

1 reference

15 August 2017

William M Merritt

6

1 reference

15 August 2017

Nicholas B Jennings

7

1 reference

15 August 2017

Robert R Langley

8

1 reference

15 August 2017

George D Yancopoulos

10

1 reference

15 August 2017

Lee M Ellis

11

1 reference

15 August 2017

Robert B Jaffe

12

1 reference

15 August 2017

Robert L Coleman

13

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 April 2008

1 reference

American Journal of Obstetrics and Gynecology

15 August 2017

1 reference

15 August 2017

198

1 reference

15 August 2017

4

1 reference

15 August 2017

477.e1-9; discussion 477.e9-10

1 reference

Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Vascular endothelial growth factor (VEGF) pathway as a therapeutic target in gynecologic malignancies

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Stress hormone-mediated invasion of ovarian cancer cells

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Lessons from phase III clinical trials on anti-VEGF therapy for cancer

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

The biology of VEGF and its receptors

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Developmental roles of platelet-derived growth factors

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Molecular determinants of ovarian cancer plasticity

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Angiogenesis in cancer and other diseases

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Pericyte loss and microaneurysm formation in PDGF-B-deficient mice

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Targeting the platelet-derived growth factor receptor in antivascular therapy for human ovarian carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Tissue-specific microvascular endothelial cell lines from H-2K(b)-tsA58 mice for studies of angiogenesis and metastasis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Vascular endothelial growth factor expression in early stage ovarian carcinoma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2346589

Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer

20 September 2018

1 reference

12 December 2020

Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival

1 reference

12 December 2020

Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer

1 reference

12 December 2020

Tridimensional views of the relationship of pericytes to endothelial cells of capillaries in the human choroid and retina

1 reference

12 December 2020

Pericyte endothelial gap junctions in human cerebral capillaries

1 reference

12 December 2020

Vascular endothelial growth factor and its receptors

1 reference

12 December 2020

Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer

1 reference

12 December 2020

10.1016/J.AJOG.2007.12.028

Identifiers

DOI

1 reference

15 August 2017

1 reference

15 August 2017

1 reference